Vaccines play a critical role in preventing and controlling infectious diseases, particularly in the face of new and emerging threats. This session will focus on the development, challenges, and impact of vaccines designed to combat emerging infectious diseases, including those caused by novel pathogens and re-emerging threats.
Bacterial and viral vaccines are critical tools in preventing infectious diseases caused by bacteria and viruses. This session will cover the science behind these vaccines, their development, and their impact on public health. It will also explore challenges and advancements in vaccine technology.
Respiratory diseases, caused by various bacteria and viruses, are among the leading causes of illness and death worldwide. Vaccines play a pivotal role in preventing these diseases, especially in vulnerable populations. This session will focus on the development, effectiveness, and challenges of vaccines targeting respiratory pathogens.
Cancer vaccines and immunotherapy represent cutting-edge approaches in oncology, aiming to harness the body's immune system to prevent and treat cancer. These therapies have revolutionized cancer treatment by offering more targeted and personalized options. This session will explore the development, mechanisms, and clinical applications of cancer vaccines and immunotherapy.
Vaccine clinical trials are a critical step in the development of vaccines, ensuring their safety, efficacy, and immunogenicity before they are approved for widespread use. This session will cover the phases of vaccine clinical trials, the ethical considerations involved, and the challenges in conducting these trials, particularly during public health emergencies.
The rise of antibiotic-resistant bacteria is a significant global health challenge, making infections harder to treat and increasing the risk of severe illness and death. Vaccines offer a promising strategy to prevent infections caused by antibiotic-resistant bacteria, reducing the need for antibiotics and helping to control the spread of resistance.
Immune characterization involves analyzing the components and functions of the immune system to understand how it responds to diseases, including infections, cancers, and autoimmune disorders. This field is essential for developing targeted therapies, vaccines, and diagnostic tools. This session will explore the methods and applications of immune characterization in research and clinical practice.
Vaccine adjuvants are substances added to vaccines to enhance the body's immune response to the antigen. They play a crucial role in improving the efficacy of vaccines, particularly in cases where the antigen alone is not sufficient to elicit a strong or long-lasting immune response. This session will cover the types, mechanisms, and development of vaccine adjuvants, as well as their role in modern vaccine formulations.
Vaccine technology and delivery platforms are at the forefront of modern immunization efforts, enabling the development of more effective, stable, and accessible vaccines. These innovations address the challenges of traditional vaccine development and are crucial for responding to emerging diseases. This session will explore the latest advancements in vaccine technology and the various platforms used for vaccine delivery.
Vaccine safety and efficacy are fundamental aspects of vaccine development and public health. Ensuring that vaccines are both safe and effective is crucial for their acceptance and widespread use. This session will delve into the processes and criteria used to evaluate vaccine safety and efficacy, the regulatory frameworks that govern these assessments, and the challenges faced in maintaining public trust.
The manufacturing and regulatory processes for vaccines are critical to ensuring that they are produced safely, effectively, and in compliance with global standards. These processes involve complex steps and rigorous oversight to maintain quality and efficacy from production to distribution. This session will cover the key aspects of vaccine manufacturing and the regulatory frameworks that ensure vaccine safety and effectiveness.
Mucosal vaccines are designed to elicit an immune response at mucosal surfaces, such as the nasal passages, oral cavity, and gastrointestinal tract. These vaccines aim to protect against pathogens that enter the body through mucosal routes and offer advantages over traditional injectable vaccines in terms of ease of administration and potential for broader protection.
Pediatric vaccines are specifically formulated to protect children from infectious diseases, which can be particularly severe or life-threatening in younger populations. This session will cover the development, importance, and implementation of vaccines for children, as well as the challenges and advancements in this field.
Plant-derived vaccines represent an innovative approach to vaccine production, utilizing plants to produce vaccine antigens. This method leverages the inherent advantages of plants, such as scalability and cost-effectiveness, to create vaccines that can be used to prevent and treat various diseases. This session will explore the science, benefits, and challenges of plant-derived vaccines.
Veterinary vaccines are essential tools for preventing and controlling infectious diseases in animals, including livestock, pets, and wildlife. These vaccines help improve animal health, enhance productivity, and reduce the risk of zoonotic diseases (diseases that can be transmitted from animals to humans). This session will explore the development, types, and impact of veterinary vaccines.
DNA vaccines are an emerging technology that involves using plasmid DNA to induce an immune response. This approach offers several advantages over traditional vaccines, including rapid development, ease of production, and potential for targeting a broad range of diseases. This session will explore the latest advancements in DNA vaccine technology, its applications, and the challenges faced.
Conjugate vaccines are a type of vaccine that combines a polysaccharide antigen from a pathogen with a protein carrier. This approach enhances the immune response to polysaccharide antigens, which alone may not provoke a strong or long-lasting immune response, particularly in young children. This session will cover the principles, development, and impact of conjugate vaccines.
Human papillomavirus (HPV) vaccines are designed to prevent infections by HPV, a group of viruses that can lead to various cancers, including cervical, anal, and oropharyngeal cancers, as well as genital warts. These vaccines are a crucial tool in reducing the burden of HPV-related diseases. This session will explore the development, types, and impact of HPV vaccines.
Vaccines against sexually transmitted infections (STIs) are vital tools in preventing the spread of these diseases, which can have significant health impacts and contribute to public health challenges. This session will explore the development, types, and effectiveness of vaccines designed to protect against common STIs.
Recombinant vaccines are a type of vaccine created using recombinant DNA technology, where genes encoding antigens from pathogens are inserted into expression systems to produce the antigens. These vaccines offer several advantages, including the ability to produce specific antigens in large quantities and enhance safety by avoiding the use of live pathogens. This session will explore the principles, applications, and developments in recombinant vaccine technology.
Vaccine development involves a range of strategies to create effective vaccines that prevent diseases and protect public health. Each approach aims to stimulate a robust and long-lasting immune response against specific pathogens. This session will cover the key approaches used in vaccine development, including their principles, applications, and challenges.
Bioprocessing and manufacturing are critical stages in the development of biological products, including vaccines, biologics, and therapeutic proteins. These processes ensure that products are produced efficiently, safely, and in compliance with regulatory standards. This session will delve into the principles, technologies, and challenges associated with bioprocessing and manufacturing in the biotechnology and pharmaceutical industries.
Vaccine hesitancy refers to the delay or refusal to vaccinate despite the availability of vaccination services. It is a growing concern for public health, impacting vaccination coverage and disease prevention efforts. Effective public health communication is crucial in addressing vaccine hesitancy and promoting vaccine acceptance. This session will explore strategies to overcome vaccine hesitancy and improve public health messaging.
The One Health approach recognizes the interconnectedness of human, animal, and environmental health. This holistic perspective emphasizes the importance of addressing health issues across these domains to improve overall health outcomes. In the context of vaccines, the One Health approach focuses on the development, distribution, and impact of vaccines across humans and animals, and their role in preventing zoonotic diseases and managing public health threats. This session will explore how the One Health approach is applied to vaccine strategies and its benefits for global health.
By using our websites, you fully and legally accept our terms and conditions. we reserve the right to modify these Terms at any time without prior notice. The most current version of the Terms will always be accessible via the link at the bottom of the Site. Continued use of the Site following the posting of any changes constitutes your acceptance of the revised Terms. Please review the Terms periodically for any updates or modifications. If you do not agree to the terms, you are not authorized to use the site.
Different modes of payment:
Online Mode: Payment for registration can be made separately from the respective conference websites. We have two International Payment gateways: Stripe and PayPal. Both accept payments from all types of cards credit/debit, Visa, Mastercard, and Discover credit cards. American Express cards are not accepted for payment. All the cards must have international transaction enabled. For some payments respective may ask for authorization for completion of registration. We accept in all three currencies USD, EUROs & GBP.
Encryption and Security: the online mod of registration is secured and end to end encrypted. We don’t save or share credit card personal information anywhere, ensuring secure transmission of participant data.
Wire Transfer: Wire/bank transfer can be done from any country. We accept in all three currencies USD, EUROs & GBP.
Offline Mode: This mode of payment is only applicable for cash payment at the registration desk to the conference organizers.
Respective conference hotels confirm hotel reservations from the organizers only after receiving of full payment. Booked accommodations can be cancelled before 45-30 days before the Check in date. It varies from country-to-country hotel policies. Less than 45-30 days of the event, change in the check in-check out date and cancellation will not be allowed and will not be entitled for refund.
Insurance cost is not included in the registration. Registrants are responsible for their parking and transportation. Shuttle facility to and from airport to hotel varies from hotel to hotel. We request you to obtain correct information of the hotel from conference manager or directly from hotel.
Invitation letters will be issued only to the paid registered attendees.
If the registrants are unable to attend for any valid reason are eligible to substitute to another speaker or delegate at least 30 days before the event, request should be made in writing to info@c2pforum.com.
Only fully paid registration including Accommodations (in case) are eligible for transfer of their registration fee to the conference scheduled for the following year, if it falls within 12 months from the date of the affected/cancelled conference. However, the organizers reserve the right to approve or deny such transfer requests, likely to manage logistical and administrative considerations. Discounted cost paid towards accommodation are not eligible to transfer. The registrations transferred are not eligible for any reimbursement.
Filming or recording the conference presentation are not allowed due to privacy concerns from the attendees. Organizer photographer will take the snaps which will be sent to everyone once we get them after editing post 15 days of the event. Participants not interested in filming need to inform in writing to the organizers in prior.
Attendees are sole responsible for the content you upload during the submission process. You must obtain necessary permissions from content owners and indemnify C2P for any failures in obtaining such permissions. C2p will not be responsible for ant third-party content or external links on the website. The attendee will be solely responsible for all their belongings at the venue. Whatever be the reason the organizer will not be responsible for any stolen or missing items of attendees.
By registering for the conference, you authorize C2P Forum to capture, record, and utilize your name, likeness, image, and comments. This includes the right to publish, reproduce, exhibit, distribute, broadcast, edit, and/or digitize these materials in publications, advertising materials, or any other form, worldwide, without compensation. Please note that photographing and/or videotaping during any session is strictly prohibited. For any queries, please contact us.
Heading in the terms and conditions are given for the convenience of readers. It is highly advisable to readd all the terms and conditions before proceeding as it is completer responsibility of the reader only. For any specific queries or clarification, it is advised to contact the conference manager and C2P directly.